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Abstract 
 
EFFECTS OF EXERCISE INDUCED MUSCLE DAMAGE ON NEUROPLASTICITY 
AND STIFFNESS 
 
John William Mackall 
B.S. Salisbury University 
 
Chairperson:  Alan R. Needle, Ph.D. 
 
 
 Musculoskeletal injuries are one of the leading causes of disability within 
the general population. Acutely, injury can cause pain, inflammation, and feelings 
of stiffness impacting the nervous system as well as the muscle to control the 
injured segment. However, studying injuries in an acute environment can pose 
challenges with respect to controls and timing of measurement. Exercise-induced 
muscle damage (EIMD) is also known to alter muscular stiffness and cause pain 
acutely; therefore, it was the goal of this thesis to examine if EIMD could 
describe mechanical and neural changes in vivo. Changes in muscle architecture, 
tendon stiffness, reflexive inhibition, and intracortical inhibition were observed 
over 72 hours following EIMD. Twelve untrained subjects took part in a muscle 
damage protocol of eccentric calf contractions (10 sets of 10 repetitions at 75% of 
one repetition maximum) on an isokinetic dynamometer. They were then tested 
for pennation angle and fascicle length via ultrasound, tendon stiffness using the 
tendon displacement method, reflexive inhibition by the Hoffman reflex (H-
Reflex), and intracortical inhibition as determined by cortical silent period (CSP). 
 v 
Testing took place before muscle damage, 10 minutes, 24 hours, and 72 hours 
after muscle damage. No significance was found in any measure despite a 
significant increase in pain; however, large effect sizes were observed of 
decreased CSP at 110% of motor threshold (μp
2=0.302) and decreased fascicle 
length (μp
2=0.163). These results though are underpowered for both CSP 
(p=0.135) and fascicle length (p=0.114). From this, it can be said that resting 
muscle tone could have been altered. More investigation is needed to confirm 
these effects. Further, examination across different muscle groups would help to 
further these conclusions.   
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Chapter 1: Introduction 
Unintentional musculoskeletal injuries are a leading cause of disability among the 
general population (Hauret, Jones, Bullock, Canham-Chervak, & Canada, 2010). In 
addition to the immediate impacts of injury such as pain and limited mobility, long-term 
injury negatively affects an individual’s capacity to perform physical activity and 
ultimately is a deterrent towards overall health (Anandacoomarasamy & Barnsley, 2005; 
Maffulli, Longo, Gougoulias, Loppini, & Denaro, 2010). Specifically, joint injury is 
known to modify neuromechanical function, leading to long-term changes in the 
morphology and neural control of a segment; however, little is known about the acute 
effects of joint injury, or how musculotendinous damage affects neural and mechanical 
properties of the joint. Few studies yet have looked at the acute mechanical or 
neuromechanical changes as the severity of injury and timing are hard to control. 
Exercise-induced muscle damage (EIMD), micro-tearing of muscle fibers due to intense 
exercise, potentially offers a repeatable, controlled model to better understand how pain 
and stiffness are modified in injury models and explain how the nervous system is 
affected (Allen, 2001; Baker, 1984).  
Musculoskeletal injuries are often associated with decreased joint stiffness, often 
due to direct damage to stabilizing structures such as ligament (Needle, Kaminski, et al., 
2017). Stiffness may be further affected by alterations in sensorimotor control, whereby 
injury impacts the ability of the dynamic joint stabilizers, such as muscle, to 
appropriately stress-shield the joint. In fact, this sensory degradation has been proposed 
to impact central nervous system function by creating a negative feedback loop of altered 
sensation and inappropriate muscular responses. These changes are theorized to induce 
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neuroplasticity and subsequently alter sensorimotor function (Needle, Lepley, & Grooms, 
2017). What is unknown are the acute effects to neuroplasticity and joint function after 
injury. Alterations in muscular stiffness is a well-known effect of EIMD and injury, in-
turn resulting in decreased range-of-motion and impaired motor control (Clarkson, 
Nosaka, & Braun, 1992; Hoang, Herbert, & Gandevia, 2007). While it has been well 
established that EIMD increases muscle stiffness (Hoang et al., 2007; Howell, Chleboun, 
& Conatser, 1993), whether neural influences have a role in these increases has not yet 
been investigated. 
Tendon stiffness and muscle architecture are known contributors to joint stiffness 
(Latash & Zatsiorsky, 1993; Singer, 2009). There is reason to believe muscle architecture 
and tendon stiffness change following EIMD. The micro-tearing which occurs from 
EIMD damages the z-lines altering parallel elastic component of muscle (Newham, 
McPhail, Mills, & Edwards, 1983); therefore, it stands to reason that some damage would 
occur in the series elastic component. Damage to the series elastic component, such as the 
tendon unit, would alter the stiffness of the joint making gross motor movement difficult 
as force production of the muscle decreases (Lieber, Roberts, Blemker, Lee, & Herzog, 
2017). However, most methods for evaluating tendon stiffness in vivo are indirect 
(Latash & Zatsiorsky, 1993), thereby limiting the conclusions that can be inferred. Newer 
methods for determining tendon stiffness such as the tendon-displacement model which 
directly measures tendon stiffness via ultrasound (Rosager et al., 2002) could provide 
accurate insight to tendon stiffness alterations. Pennation angle (PA) and fascicle length 
(FL) are properties of muscle architecture and may influence joint stiffness, and although 
studies have measured changes in PA and FL after muscle fatiguing (N. M. Thomas, 
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Dewhurst, & Bampouras, 2015), no study has examined their changes after EIMD. 
Factors though such as inflammation and potential altered neural output, resulting in 
muscle tone changes, may acutely alter these measures. Studying these changes following 
EIMD will give further insight to the mechanical contributions of joint stiffness.  
Reflexive inhibition is known to occur following ligamentous injury as damage 
occurring to the sensory receptors, inflammation, and pain result in arthrogenic muscle 
inhibition (AMI), a type of reflexive inhibition (McVey, Palmieri, Docherty, Zinder, & 
Ingersoll, 2005). AMI describes the altered communication between the joint and nervous 
system and is associated with degraded spinal reflexes of the affected joint (McVey et al., 
2005). Type III and Type IV afferent sensory fiber activation decreases the excitability of 
the alpha motor neuron pool causing AMI. The greater the inhibition the less excitable 
the muscle is to reflexive stimulus, thereby decreasing the ability to activate the muscle 
(Palmieri-Smith, Villwock, Downie, Hecht, & Zernicke, 2013). What is not yet clear is if 
this same response can occur due to damage to Type I and Type II afferent fibers. EIMD 
would be more likely to cause damage to Type I and Type II afferents with minimal to no 
damage to Type III and Type IV afferents with similar increases in nociception. The 
degree of reflexive inhibition can be determined by using the Hoffmann reflex (H-reflex) 
in which electrical stimuli are used to evoke direct responses (M-waves) and reflexive 
responses (H-waves) from the muscle. The ratio of the maximal H-wave to the maximal 
M-wave allows the investigator to observe the reflexive abilities of the muscle. 
 Intracortical inhibition resulting from altered outputs of the brain may occur due 
to pain following injury and subsequently contributes to muscle stiffness and resting 
muscle tone (Needle, Charles, et al., 2013). The afferent influx secondary to pain may 
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result in a decrease in Gamma aminobutyric acid (GABA)-related activity in the cortex 
would increase descending drive to the muscle, resulting in greater muscle tone and 
stiffness. This GABA-response to pain has only been observed in ligamentous injury and 
CNS dysfunctions such as stroke or dystonia (Hallett, 2011). EIMD would then be a 
novel approach in which to observe this response. The cortical silent period (CSP) 
represents a period of relative muscular silence following a motor evoked potential 
induced from transcranial magnetic stimulation. The length of this period is proportional 
to the amount of GABA activity in the brain and has been associated with the amount of 
joint stiffness. (Catano, Houa, & Noel, 1997; Kimberley et al., 2009; Trompetto et al., 
2012; Werhahn, Kunesch, Noachtar, Benecke, & Classen, 1999). 
By understanding the neural and mechanical contributions behind EIMD, 
researchers and practitioners will be able to develop better methods to minimize and treat 
injury. Previous research has established injury-induced neuroplasticity in chronic injury 
models, as well as EIMD-induced muscle stiffness changes, but no study has before 
sought to link these properties in a single cohort in vivo. These results will help to 
illustrate the mechanical and neural contributions of EIMD which may be relayed back to 
injury. Furthermore, by examining these properties concurrently over time from the onset 
of damage, the understanding of musculotendinous pathology may be enhanced to 
improve treatments and minimize performance deficits. We therefore aim to achieve 
these goals by pursuing the following specific aims: 
Specific Aim 1: To concurrently examine changes in tendon stiffness and muscle 
architecture over 72 hours following EIMD. 
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Hypothesis 1.1: Tendon stiffness will increase at all time points following EIMD. 
Hypothesis 1.2: Pennation angle will increase and fascicle length will decrease at all time 
points following EIMD. 
Specific Aim 2: To examine changes to reflexive and intracortical inhibition over 72 
hours following EIMD. 
Hypothesis 2: Reflexive inhibition will increase and cortical disinhibition will occur 
following EIMD. 
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Chapter 2: Review of Literature 
2.1. Introduction 
 Exercise induced muscle damage (EIMD) is a widely studied topic. From its 
initial descriptions in 1900 by Hough, there have been numerous studies conducted as to 
its nature and cause. The purpose of this review is to describe what EIMD is, the 
competing mechanistic theories as to its occurrence, and its effect on tendon stiffness, PA 
and FL, reflexive and intracortical inhibition. This review will also draw connections 
between the etiologies of EIMD and musculotendinous injury and how EIMD can be 
viewed as a model of musculotendinous injury. 
2.2. Exercise Induced Muscle Damage 
2.2.1. Definitions 
 EIMD is the phenomena resulting from eccentric muscle exercise or active 
lengthening of muscle. It occurs primarily in unaccustomed people and includes a myriad 
of symptoms. These include delayed onset muscle soreness (DOMS) (Armstrong, 1984), 
damage to the sarcomeres (Morgan & Allen, 1999) and extra-cellular matrix (ECM), 
decreases in muscle force production, increases in joint passive stiffness, and onset of 
muscle inflammation (Clarkson et al., 1992; Hough, 1900).  Hough, in 1900, described 
his unaccustomed subjects as becoming sore days after the activity along with a marked 
decrease in the force producing capability of the muscle in this same range of time. He 
hypothesized that the muscles in these subjects became damaged by rupture of the 
muscles themselves causing these symptoms (Hough, 1900). Since then, many studies 
have been conducted resulting in competing mechanistic theories as to what causes these 
wide arrays of effects. 
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2.2.2. Differences between Muscle Fatigue and Damage 
 EIMD is distinct and different from muscular fatigue. Hough first described 
fatigue by showing that tetanic contractions caused soreness during and immediately 
following exercise. However, soreness did not occur days later in tetanic contractions as 
was observed with concentric and eccentric contractions (Hough, 1900). Newham et al 
established that the eccentric portion of muscle activity that caused soreness and damage 
(Newham et al., 1983). Subjects performed eccentric contractions on one leg and 
concentric contractions on the contralateral leg. The biopsies taken showed damage to the 
muscle fibers on the leg that performed eccentric activity while subjects also reported 
DOMS on that same leg as well. The researchers were able to conclude that active muscle 
lengthening caused EIMD.  
 Fatigue differs in that it is largely neuromuscular and is caused by 
isometric/tetanic activity and concentric exercise (Hough, 1900; Newham et al., 1983).  
Further, fatigue is not associated with damage to the muscle. 
2.3. Mechanisms 
2.3.1. Popped Sarcomere Theory 
 The most prevalent theory in the literature to describe EIMD is termed the 
“popped sarcomere” theory. When active muscle is stretched beyond a yielding point, the 
force-lengthening relationship of the sarcomere is shifted to longer lengths (Katz, 1939). 
This would indicate that the sarcomeres were stretched to a yielding point which in turn 
increased its resting length. The occurrence of this resting length shift indicated damage 
to the structure. In essence, the sarcomere “pops.” Friden et al. took muscle biopsies of 
human subjects who had performed eccentric exercise and showed evidence of damage to 
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individual sarcomeres (Friden, Sjostrom, & Ekblom, 1981). The term “popped 
sarcomere” was coined by D.L. Morgan (Morgan, 1990). Morgan assumes a non-uniform 
sarcomere model (Morgan, Mochon, & Julian, 1982), where when activated and 
stretched, the sarcomeres with the least amount of overlap of thick and thin filaments will 
“pop” or rather shear first (Morgan & Proske, 2004). The process of sarcomere 
“popping” continues as the muscle lengthens until the rising passive tension accounts for 
the falling active tension (Morgan & Proske, 2004). This leads to the damage of ECM 
(Lieber, Loren, & Friden, 1994; Stauber, Clarkson, Fritz, & Evans, 1990). There is 
evidence for this occurring supported by many studies. Animal and human models have 
shown that sarcomeres, as well as the ECM, become damaged following eccentric 
activity (Crameri et al., 2007; Friden et al., 1981; Lieber et al., 1994; Newham, Jones, 
Ghosh, & Aurora, 1988; Gordon L Warren, Ingalls, Lowe, & Armstrong, 2002; 
Whitehead, Weerakkody, Gregory, Morgan, & Proske, 2001; Yu, Carlsson, & Thornell, 
2004).  
2.3.2. Excitation-Contraction Coupling Failure 
 The other prevalent mechanism of force reduction is excitation-contraction (EC) 
coupling failure. Experiments conducted using caffeine supplementation showed there 
was no difference between force production of damaged and control muscle. Caffeine 
induces release of calcium from the sarcoplasmic reticulum (SR) allowing for an 
abundance of calcium within the sarcomere. This leads to the conclusion that there is a 
reduction of stimulus to release calcium from the SR due to EIMD; thereby, decreasing 
muscle force generation (G. L. Warren et al., 1993). 
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 A marked reduction in the amount of calcium in the sarcomere has been observed 
in eccentrically damaged mouse muscle (G. L. Warren et al., 1993). Further, a paper by 
Warren et al published in 2002 stated that EC coupling failure could account for 75% of 
reduction in force producing capabilities in the first three days following EIMD with the 
remaining 25% being due to structural damage. After this time, structural damage is the 
primary cause of force reduction (Gordon L Warren et al., 2002). 
2.3.3. Overlap of Popped Sarcomere and EC Coupling Mechanisms  
 It is important to realize that these mechanisms are not mutually exclusive of each 
other but rather inter-related. Morgan has since been able to show that the popped 
sarcomere theory can help explain why EC coupling failure occurs. Damage to the t-
tubules has been shown to account, at least in portion, for the reduction in calcium release 
from the SR (Morgan & Proske, 2004). It is likely that these competing theories 
harmoniously describe the occurrence of force production loss.  
2.4. Musculotendinous Stiffness 
2.4.1. Measures of Stiffness 
 Stiffness in classical mechanics describes the deformation of a spring in relation 
to the force applied. Hooke’s Law describes this relationship: 𝐹 = −𝑘𝑥. F is force 
applied, x is deformation, and k is the spring constant. The spring constant is an inherent 
property of the spring. The negative term indicates that it is a restoring force with an 
equilibrium point. Muscles and tendons are often described by their spring-like 
characteristics. Terms such as muscle stiffness, tendon stiffness, and joint stiffness are 
often seen in the scientific literature to describe the spring-like characteristics. It should 
be noted that there are different measures of stiffness such as quasi-stiffness which is 
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independent of time and apparent stiffness in which measurement is taken at equilibrium 
while ignoring some of the physical nature of the spring (Latash & Zatsiorsky, 1993). 
 Tendons have a unique stiffness constant due to uniform nature of the tissue. 
Tendon is composed of collagenous tissue unlike muscle which is made up of various 
proteins and involve these proteins actively contracting. This allows tendon to be 
modeled as a spring. 
Muscle too is often modeled as spring despite the properties described above. The 
Hill muscle model demonstrates that muscle has elastic components, a series elastic 
component (SEC) and parallel elastic component (PEC), which accompany the 
contractile component (CC) (Close, 1972; Hill, 1950). Methods to evaluate the elastic 
components, SEC and PEC, of muscle in vivo involve the subjects relaxing the tested 
muscle to remove the CC and is often called passive stiffness. When evaluating stiffness 
of active muscle, in methods such as free-oscillation (Fukashiro, Noda, & Shibayama, 
2001), the PEC is often ignored as it is far more compliant than the SEC. It is also 
assumed that sarcomere length remains uniform (Latash & Zatsiorsky, 1993). These 
factors make it difficult to attribute a stiffness constant to muscle. 
 Joint stiffness describes the combined actions of muscle and tendon to control 
movement around a joint. This is typically done in a passive manner. The joint is 
manipulated throughout a set range of motion by a dynamometer while the muscles relax. 
This reduces the effects of the CC allowing for the elastic components to be measured 
(Latash 1993). Further, it can be used to evaluate the contribution of reflex loops to 
stiffness regulation. 
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2.4.2. EIMD and Stiffness 
 A noted characteristic of EIMD is the increase in stiffness of the joint (Armstrong, 
1984; Hoang et al., 2007; Howell et al., 1993; McHugh et al., 1999; Morgan, 1994). 
Studies have shown that passive stiffness measures rise after EIMD for at least 48 hours 
post damage (Hoang et al., 2007; Howell et al., 1993; Whitehead et al., 2001). The length 
of time to return to baseline levels differs among the literature, but there seems to be a 
consensus that normal passive stiffness is restored within about a week post EIMD. The 
rise in passive stiffness has been attributed to EC coupling mechanism (Morgan et al., 
1982; Gordon L Warren et al., 2002). When damage occurs the sarcomeres are unable to 
regulate the flow of calcium from the SR. Calcium then stays in the sarcomere causing 
increased sarcomere cross-bridging at rest. This increases tension of the CC which further 
puts stress on the SEC. Overall, this causes a rise in joint stiffness. 
2.4.3. Measuring Tendon Displacement to determine Tendon Stiffness  
 The literature is lacking is in its ability to distinguish tendon stiffness from muscle 
stiffness. Previous models used involve many assumptions and does not directly use 
Hooke’s Law to determine a spring constant. With the use of an isokinetic dynamometer 
and ultrasound, force and tendon displacement can be directly measured. According to 
the methods of Rosager et al. the ultrasound probe is fixed to the muscle-tendon junction 
and an electrical goniometer is fixed to the ankle. A passive range of motion is performed 
and a displacement versus angle graph obtained. This is to account for passive tendon 
displacement and allows for adjustment to the contraction displacement curve (Rosager et 
al., 2002). Moment arm of the ankle must be estimated in order to obtain the actual force 
production of the muscle. This model allows then for the spring constant to be obtain 
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using 𝑘 =
𝐹𝑜𝑟𝑐𝑒
𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡
.  This method has been used in other studies (Arampatzis, 
Karamanidis, Morey-Klapsing, De Monte, & Stafilidis, 2007; Kubo et al., 2007) as well 
but never in an EIMD model. 
2.5. Effects on Muscle Architecture 
Few studies have been performed examining EIMD and changes in muscle 
architecture measurements of fascicle length and pennation angle. Fascicle length is the 
total length of the fascicle which can be measure via ultrasound, and pennation angle is 
the angle formed between a fascicle and the aponeurosis of the muscle. The relationship 
of fascicle length and pennation angle is indicative of the function of pennate muscle. 
Increases in fascicle length at rest can mean that there is a lack of filament overlap; 
thereby, decreasing force production, assuming no sarcomeres have been added in series 
(Fukunaga, Kawakami, Kuno, Funato, & Fukashiro, 1997; Herzog, Read, & Ter Keurs, 
1991; Maganaris, 2003). Likewise, if fascicle length decreases, there is more filament 
overlap meaning force production has increased; however, the force production will 
decrease when the fibers become too shortened (Fukunaga et al., 1997; Rassier, 
MacIntosh, & Herzog, 1999; Woittiez, Huijing, & Rozendal, 1983).  
At rest, the higher the pennation angle the larger the physiological cross-sectional 
area (PCSA) of the muscle. A larger PCSA indicates that there are more sarcomeres in 
parallel with each other; thus, increasing the active force production capability of a 
muscle. Pennation angle is also affected by the pull of sarcomeres. This indicates that as 
the fascicle, and thereby sarcomeres, shorten, the pennation angle increases. Therefore, 
pennation angle is interdependent on fascicle length (Azizi & Roberts, 2014). 
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No studies have looked at the effects of EIMD on pennation angle and fascicle 
length. However, a recent study looked at pennation angle and fascicle length after 
isometric fatigue in the gastrocnemius medialis of humans. They found that both fascicle 
length increased and pennation angle decreased following isometric fatiguing (N. M. 
Thomas et al., 2015). This would indicate that the force production capability of the 
muscle had decreased immediately following fatigue. Another recent study proved that 
during eccentric activity, fascicles lengthen in order for there to be a greater contribution 
of the tendon to the stretch of the muscle thereby decreasing the possibility of damage to 
contractile tissue (Hoffman, Cresswell, Carroll, & Lichtwark, 2014). Neither of these 
studies have shown the changes in fascicle length and pennation angle following damage. 
2.6. Neurological Influences of Injury 
2.6.1. Arthrogenic Muscle Inhibition 
 Feedback mechanisms from the muscle to the nervous system provide reflex arcs. 
These reflexes are responsible for resting muscle tone and motor control. Following 
damage to any of the structures involved results in an arthrogenic muscle response. 
Arthrogenic muscle response results in either inhibition, which is a decrease in joint 
control, or facilitation, which is an increase in joint control. In order to quantify the 
activity of these reflexes, the H-Reflex method is used. H-Reflex tests the excitability of 
the alpha-motor neuron. Two distinct responses, H-Wave and M-Wave are seen from the 
test. The H-Wave represents the signal sent from the spinal cord to the corresponding 
muscle. The M-Wave is the initial twitch of the muscle due to direct stimulation from the 
testing apparatus. A greater H-Wave indicates facilitation; whereas, a lesser H-Wave 
indicates inhibition. The maximum of both waves is also compared in the H:M ratio. A 
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smaller ratio suggests that there are motor-neurons available for recruitment which are 
not being used. So, the greater the ratio the more inhibition indicated. 
 It has been shown in ligamentous injury that there is reflexive or AMI (McVey et 
al., 2005; Needle et al., 2014). Mechanoreceptor damage, pain, and inflammation shut 
down the reflex arc decreasing the number of motor units recruited. There is no evidence 
yet as to whether this occurs in musculotendinous injury. The etiologies are similar 
evidenced by inflammation, pain, and increased joint stiffness but has yet to be tested. 
 2.6.2. Intracortical Inhibition 
 Intracortical inhibition is known to play a key role in the maintenance of muscle 
tone and stability. Intracortical inhibition describes the inhibitory pathways in the brain 
which suppress unwanted movement. Therefore, inhibitory pathways have an important 
role in maintaining proper neuromuscular function (Heroux & Tremblay, 2006; Needle, 
Palmer, Kesar, Binder-Macleod, & Swanik, 2013; Trompetto et al., 2012).  
Intracortical inhibition can be quantified by measuring CSP using TMS and EMG. 
CSP is the time between a motor-evoked potential (MEP) and the return to normal motor 
function. The MEP is facilitated by using TMS, and the resulting motor function 
measured by EMG. TMS generates focused B-fields which pass through the skull, 
exciting the motor neurons in the brain. This causes the neurons to fire creating 
movement in the corresponding muscles. EMG electrodes placed on these muscles 
measure the resulting electrical activity. After a TMS stimulus, a spike in muscle 
electrical activity can be seen called a MEP. Following the MEP normal electrical 
activity resumes. The time period between the MEP and normal electrical activity is the 
CSP.  
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CSP is used primarily to assess people with neurological diseases such as cerebral 
palsy. From these studies it has been shown that a longer CSP indicates more inhibition 
and less joint stiffness, and shorter CSP indicates less inhibition and greater joint 
stiffness(Needle, Palmer, et al., 2013). Ligamentous injury has also been shown to alter 
CSP. EIMD is known to cause inflammation and increase joint stiffness like ligamentous 
injury. The onset of inflammation and increase in stiffness has been attributed to both 
damage of the SR function and sarcomeres. It has not been determined what changes if 
any occur in muscle tone regulation via the cortex.  
2.7. Conclusions 
 EIMD is a commonly occurring phenomena that effects almost anyone who 
exercises. The active lengthening of a muscle causes damage to the sarcomeres as well 
the ECM of the muscle resulting in pain and inflammation. These are shared 
characteristics with ligamentous injury; however, it is unknown how musculotendinous 
injury alters reflexive and intracortical inhibition and how that correlates to the changes 
in stiffness. Using EIMD as a model of musculotendinous injury should allow for insights 
to be made on this front. 
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Chapter 3: Methods 
3.1. Experimental Design 
This study utilized a repeated measures design. The independent variables were 
the timing in relation to muscle damage protocol (Pre, Post. 24 Hours, and 72 Hours). 
The dependent variables were tendon stiffness, FL, PA, Hmax:Mmax, and CSP. See Figure 
1 for a flowchart of study procedures. 
3.2. Subjects 
Twelve untrained individuals, ages 18-35, were recruited for this study. Subjects 
were untrained meaning they had not been engaged in a training regimen for at least the 
prior three months. Subjects were healthy enough to engage in weight lifting activities 
which was determined by the completion of a Physical Activity Readiness-Questionnaire 
(S. Thomas, Reading, & Shephard, 1992) form prior to beginning the study. Exclusion 
criteria included pregnant individuals due to potential health risks, those with current 
ankle injuries or a history of leg fractures and surgeries, or who regularly took anti-
inflammatory medications (i.e. ibuprofen, acetaminophen, or naproxen) as these drugs 
alter the muscle damage response.  Individuals had to also complete the TMS screening 
questionnaire (Rossi et al., 2009) to ensure the safety of the subject. The TMS exclusion 
criteria included metal or electronic implant, history of seizure, concussion within the 
past 6 months, currently pregnancy or being treated for a psychiatric or neurological 
disorder. All subjects provided Appalachian State University-approved informed consent 
(16-0256). 
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3.3. Pain Scale 
Subjects were asked to complete a pain assessment form. The form asked the 
subjects to put a vertical mark along a 10-cm horizontal line indicating the amount of 
pain in the lower leg while walking, while standing, and while sitting. Below the line was 
a visual analog scale of facial expressions to help the subject know where to draw the line 
(See Appendix). The form was completed prior to the start of all visits as well as the end 
of visit one. 
3.4. Determining Muscle Architecture 
Subjects were prone on an isokinetic dynamometer (Computer Sports Medicine 
Inc., Stoughton, MA) with a 10 MHz B-mode ultrasound probe (Telemed Echo Blaster 
128, Lithuania) placed to the medial gastrocnemius. The probe was placed at 30% the 
difference between the popliteal fold and the lateral malleolus as shown in Figure 2 
(Kawakami, Ichinose, & Fukunaga, 1998). The subject’s foot was placed with the bottom 
flat on the dynamometer footplate with the foot making a 90-degree angle with the lower 
leg. This was confirmed by using a goniometer. A high-resolution image was taken with 
the ultrasound (Figure 3). Analysis of this image was done using Kinovea software 
(Kinovea for Windows, Version 0.8.15, Kinovea.org). Pennation angle was measured at 
the smallest angle made between a fascicle and the deep aponeurosis. An average of three 
angles was taken from a single image. Fascicle length was estimated by measuring the 
thickness of the muscle. Two measurements from a single image were taken and 
averaged. Then, along with average pennation angle, fascicle length was calculated by 
the equation: 
𝑀𝑢𝑠𝑐𝑙𝑒 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠
sin(𝑝𝑒𝑛𝑛𝑎𝑡𝑖𝑜𝑛 𝑎𝑛𝑔𝑙𝑒)
= 𝐹𝑎𝑠𝑐𝑖𝑐𝑙𝑒 𝐿𝑒𝑛𝑔𝑡ℎ 
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3.5. Tendon Stiffness 
Three methods were performed to determine the moment arm. Anthropometric 
measurements of the tested leg were taken to determine moment arm of the ankle. 
Distance from the lateral malleolus to the Achilles’ tendon midline was measured as well 
as from the medial malleolus to the Achilles’ tendon midline using calipers. This was 
done to correct for perspective error of the pictures. Pictures of medial and lateral view of 
the bare foot were taken. The foot was placed on a box with a ruler on the side to give 
scale (Figure 4). Marks were made on the lateral and medial malleoli. The lower leg was 
at a 90-degree angle with the foot, and the lateral and medial edges of the foot were 
aligned with the reference block. Two pictures were taken, lateral and medial, and the 
moment arm was said to be the mean of these two calculations. This measurement was 
done once at the beginning of testing and only at the baseline measures session. These 
measurements were used in a custom MATLAB (MathWorks, Natick. MA) software to 
obtain moment arm. 
The moment arm was also measured using a tendon excursion method. Two 
different techniques (MA1 and MA2) of this method were done to check for differences. 
For muscle architecture, Ultrasound probe was fixed to the muscle tendon junction of the 
medial gastrocnemius using a custom foam holder and zinc oxide tape to ensure the probe 
stayed immobile. The subject was prone on an isokinetic dynamometer with the foot flat 
against the footplate. Straps were used to cover the top of the foot to ensure the foot 
stayed flat (Figure 5). An electro-goniometer (Biometrics, Newport, UK) was attached at 
the ankle in the sagittal plane as a check to see if the ankle angle was the same as the 
angle given by the dynamometer (Figure 6). The dynamometer then moved the ankle 
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through a 20-degree range of motion at five degrees per second. The foot started at 10 
degrees of dorsiflexion, moved to 10 degrees of plantarflexion, and then returned to 10 
degrees of dorsiflexion. For MA2, A second trial was performed, this time the ankle was 
moved through the same range of motion five times. On the fifth pass, data was collected 
on all instruments. Tracking of the muscle tendon junction was performed using Kinovea 
(Kinovea for Windows, Version 0.8.15, Kinovea.org) software. The moment arm was 
determined by using circular dynamics. The tendon excursion method models the ankle 
as a circle. To determine the radius of a circle, the change in angle and displacement must 
be known. Tendon excursion is the displacement term, and the change in angle is 
determined by the goniometer and dynamometer over five degrees of plantarflexion to 
five degrees of dorsiflexion. The moment arm is the resulting radius (Fath, Blazevich, 
Waugh, Miller, & Korff, 2010) (see below equation). 
𝑚𝑜𝑚𝑒𝑛𝑡 𝑎𝑟𝑚 =  
𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡 𝑜𝑓 𝑡𝑒𝑛𝑑𝑜𝑛
𝑎𝑛𝑔𝑢𝑙𝑎𝑟 𝑎𝑛𝑘𝑙𝑒 𝑒𝑥𝑐𝑢𝑟𝑖𝑜𝑛
. 
Once the moment arm calculations were performed, subjects then began performing 
maximal volitional isometric contractions (MVIC) with three minutes in between each 
trial to measure tendon stiffness. Ultrasound was kept in the same location from moment 
arm testing. The probe was in video mode recording at 30 frames per second. Data from 
the dynamometer, goniometer, and ultrasound were all time synched offline for analyses. 
Tendon displacement was determined by tracking the muscle-tendon junction 
using Kinovea analysis. Force was obtained by dividing the torque output of the 
dynamometer by the moment arm of the ankle and then plotted against displacement. 
Stiffness was determined at 50% - 100% of total force output and over the whole force 
output. The resultant slope is the stiffness value. Values were reported for all five 
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techniques of moment determination (MA1, MA1 with electro-goniometer correction, 
MA2, MA2 with electro-goniometer correction, and manual calculation).  
3.6. Hoffman Reflex 
Participants were instrumented with electromyography (EMG) sensors on the 
tibialis anterior (TA), soleus (SOL), and medial gastrocnemius (MG). Each muscle was 
palpated, shaved, cleaned with an alcohol swab, and abraded to ensure a quality signal 
(Basmajian, 1967). H-reflex was acquired using a Digitimer DS7AH stimulator 
(Digitimer LLC, Hertfordshire, UK) with a bar electrode applied behind the knee. Low 
intensity pulses were used to find the correct spot behind the knee just before the sciatic 
nerve bifurcates in the popliteal fossa. Brief electrical pulses of one millisecond were 
applied beginning at a low intensity and gradually increased by two mA until a maximal 
response was observed from the muscles. The direct muscle activation (M-wave, 10-
40ms) and the reflexive response (H-wave, 50- 14 100ms) was identified and peak-to-
peak values were extracted. Electromyography data was collected at 2000 Hz. The ratio 
of maximal H-wave to maximal M-wave served as a measure of reflexive excitability 
(Needle et al., 2014). 
3.7. Cortical Silent Period 
For measurement of CSP, participants kept the EMG sensors on from H-Reflex 
testing. Magnetic stimuli were delivered using a Magstim 200-2 Magnetic Stimulator 
with a double-conical coil (MagStim LTD, Wales, UK). Participants were seated in a 
chair with a tight-fitting cap on the head and provided earplugs to wear throughout testing 
(Figure 7). After familiarization with the procedures of TMS, magnetic stimuli were 
gradually applied 1cm anterior and lateral to the vertex of the skull until observable 
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motor responses were seen in the legs. This intensity was used to find the "hotspot". 
Stimuli were applied every 5 seconds as the coil was moved within a 5cm radius to 
pinpoint the location that a pulse generated the largest motor response in the leg muscles. 
This location was designated the hotspot. Next, the resting motor threshold (the exact 
magnetic intensity enough to induce a muscular contraction) was pinpointed by applying 
50-60 stimuli (with 5 seconds between each) at varying randomized intensities ranging 
from below the motor threshold to above a maximal response to generate a stimulus-
response curve. Resting motor threshold was then determined by finding were the 
response increased by 10% of maximum (Needle, Palmer, et al., 2013). 
TMS was delivered with the subject voluntarily contracting their muscles at 10 
percent of maximal effort with augmented feedback provided by the investigators. This is 
a light level of contraction designed to allow for calculation of the CSP. Ten pulses of 
90%, 110% and 130% (30 pulses total) of the resting motor threshold were applied at the 
hotspot as continuous muscle activity was recorded. 
CSP was calculated using custom LabVIEW software (National Instruments, 
Austin, TX). A series of student’s t-tests were used to compare EMG activity which had 
been logarithmically-transformed and normalized to a 4-ms window of pre-stimulus 
activity. Cursors were placed on a plot and the investigator confirmed the locations were 
accurate. The researcher then took the difference of the time from the return of voluntary 
muscle contraction and subtract from it the time at the end of the MEP (Nilsson, Panizza, 
& Arieti, 1997). 
 
 
 22 
3.8. Muscle Damage Protocol 
To begin the muscle damage protocol, a working one repetition maximum had to 
be performed to determine the level of intensity of the protocol. All instrumentation on 
the subject was removed, and they then laid prone on the dynamometer with their foot 
fixed on the footplate with straps. Subjects then performed one MVIC at 20 degrees of 
plantarflexion to determine maximal force at the end range of motion as this is the 
weakest position for the exercise. Using 75 percent of the MVIC, subjects performed ten 
sets of ten repetitions of single leg eccentric calf raises on the dynamometer while 
pushing maximally against the footplate. Repetitions only utilized the plantar flexor 
muscles with the concentric portion being one second and the eccentric portion being 
three seconds. Torque threshold for the concentric portion was set at 10 foot-pounds. 
Each repetition consisted of the subject moving from 10 degrees of dorsiflexion to 20 
degrees of plantarflexion and back to dorsiflexion (Figure 8). One minute of rest was be 
given between sets. The dynamometer ensured a full range of motion was done for each 
repetition. The eccentric torque limits of the dynamometer were lessened by 5 foot-
pounds a set as fatigue was observed by practitioner so all completed 100 repetitions. 
3.9. Statistical Analyses 
Statistical analyses were performed using IBM SPSS software. PA, FL, tendon 
stiffness, and CSP were assessed with a one-way analysis of variance (ANOVA) with 
time as the within-subjects factor. Time had four levels: pre, post, 24 hours post, and 72 
hours post.  H-Reflex was assessed using a factorial ANOVA because there are two 
independent variables, time (4 levels) and muscle (3 levels). The a priori significance 
level was set at 0.05. Partial eta-squared was used to assess the effect size (0.01 ~ small, 
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0.06 ~ medium, 0.14 ~ large) (Cohen & Cohen, 1983). Further, Fisher’s least significance 
difference comparisons was used to find post hoc differences between levels of the 
independent variables in the case of significant main or interaction effects. 
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Chapter 4: Results 
4.1. Subjects 
 Untrained males (n = 9) and females (n = 3) participated in the current study        
(age: 22.4 ± 2.7 years; body mass: 82.6 ± 19.8 kg; height: 176.3 ± 6.9 cm). Six of these 
subjects performed the TMS measures due to an adverse event, which occurred during 
testing. The testing leg was determined by a coin flip in which eight subjects performed 
the protocol on the right leg and four subjects on the left leg. 
4.2. Pain Scale 
Pain values are presented in Table 1. For pain while walking there was a 
significant main effect of time (F[3,33] = 4.280, p = 0.012, μp
2 = 0.280). From post-hoc 
comparisons, pain while walking was greater at 24-hours than at baseline (p = 0.007). 
Pain while walking at 24-hours was also significantly greater than at 72-hours                
(p = 0.041). All other times were non-significant from each other. For pain while 
standing there was not a significant effect of time (F[3,33] = 1.218, p = 0.319, μp
2 = 0.100). 
For pain while sitting data violated Mauchly’s test of sphericity (W = 0.231, p = 0.011); 
and therefore, a Greenhouse-Geisser adjustment to the degrees of freedom was used. 
There was not a significant effect of time (F[1.938,21.270] = 1.330, p = 0.281, μp
2 = 0.180).  
4.3. Muscle Architecture 
Values of PA and FL are presented in Table 2. For FL there was no significant 
effect of time (F[3,33] = 2.139, p = 0.114, μp
2 = 0.163). For PA there was no significant 
effect of time (F[3,33] = 0.734, p = 0.5374, μp
2 = 0.048).  
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4.4. Moment Arm 
Moment arm values are presented in Table 3. For moment arm, there was no 
significant effect of time (F[3,33] = 0.346, p = 0.793, μp
2 = 0.030). The effect of technique 
violated sphericity (W = 0.272, p = 0.028). Using the Greenhouse-Geisser correction 
there was a significant difference between techniques (F[2.679,29.474] = 76.368, p < 0.001,               
μp
2 = 0.874). The interaction of technique and time also violated sphericity (W = 0.000,   
p = 0.002). The Greenhouse-Geisser Correction was used and no significance was found 
(F[1.662,44.958] = 0.407, p = 0.775, μp
2 = 0.036). 
Comparisons showed that electro-goniometer correction for MA1 and MA2 were 
significantly greater than MA1 without electro-goniometer correction with p = 0.002 and 
p = 0.007 respectively. Further, they were also significantly greater than MA2 without 
electro goniometer correction with p = 0.009 and p = 0.002 respectively. The 
anthropometric determination of moment arm was done only once at the onset of testing 
and does not have the level of time. Using pairwise comparisons this determination of 
moment was significantly greater than all the four other techniques all with p < 0.001. 
4.5. Tendon Stiffness 
Tendon Stiffness was determined using the force production range and over 50% - 
100% of maximum force production with all 5 techniques of moment arm being used. 
There was no main effect of time for any determination of tendon stiffness. All means, 
standard deviations, F-values and P-values are reported in Table 4. Average maximum 
force from MVIC trails were also computed. All means, standard deviations, F-values, 
and P-values are reported in Table 5. 
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4.6. Reflexive Inhibition 
Descriptive statistics for reflexive inhibition can be seen in Figure 9. For H-
Reflex, the interaction between muscle and time violated sphericity (W = 0.001,              
p < 0.001). Greenhouse-Geisser correction was used with the interaction between muscle 
and time did not yield significant (F[1.717,17.170] = 0.758, p = 0.605, μp
2 = 0.070). Within 
muscle, SOL was greater than both TA (p = 0.032) and MG (p < 0.001). The effect of 
time was not significant (F[3,30] = 0.231, p = 0.874, μp
2 = 0.023). The effect of muscle was 
significant (F[2,20] = 9.268,  p = 0.001, μp
2 = 0.481).  
4.7. Intracortical Inhibition 
CSP was only performed on six subjects as there was an adverse event from TMS 
which occurred during testing. Descriptive statistics of CSP can be seen in Figure 10. For 
CSP at the 130% level, the effect of time was not significant (F[3,12] = 0.624, p = 0.613,       
μp
2 = 0.135). For CSP at the 110% level, the effect of time was also not significant         
(F[3,15] = 2.165, p = 0.135, μp
2 = 0.302).  
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Chapter 5: Discussion 
5.1. Introduction 
 The purpose of this study was to examine the changes of muscle architecture, 
tendon stiffness, reflexive inhibition, and cortical inhibition over 72 hours following a 
single bout of EIMD in the triceps surae. It was hypothesized that FL and PA would 
increase, tendon stiffness would increase, reflexive inhibition would increase, and 
intracortical inhibition would decrease after EIMD. Despite the increases in pain, there 
were no significant changes to muscle architecture, tendon stiffness, reflexive inhibition, 
or intracortical inhibition. FL and CSP though were bordering on significance with large 
effect sizes suggesting that resting motor tone may have increased, although a larger 
sample would be required to draw this conclusion. These results indicate that acute 
changes in stiffness due to EIMD may be a result of the neurological changes as opposed 
to mechanical, but further investigation is needed before any consensus is reached.  
5.2. Muscle Architecture 
 PA and FL were assessed to quantify muscle architecture following EIMD as they 
can serve as markers for muscle tone and stiffness. The triceps surae are 3 pennate 
muscles, with the degree of pennation proportionate to force output and muscle tone 
(Maganaris, 2003; Singer, 2009). FL is associated with several factors, such as the 
number of sarcomeres in series, the filament overlap (Hodges, Pengel, Herbert, & 
Gandevia, 2003), or the amount of fluid levels (Bakke et al., 1996). Knowing that muscle 
stiffness increases following EIMD (Clarkson et al., 1992), it was predicted that PA 
would increase and FL would decrease following EIMD. To our knowledge, PA and FL 
have not been assessed previously in EIMD models. The results did not show statistically 
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significant changes in either measure. FL though is nearing significance (p = 0.114) with 
a large effect size (η2 = 0.163) indicating FL may have decreased and resting muscle tone 
and muscle stiffness increased. A study done in 2015 looked at muscle architecture in 
fatigued muscles and showed that FL increased and PA decreased (N. M. Thomas et al., 
2015) indicating that acute exercise can alter muscle architecture. The difference here 
though is that this is a fatiguing model whereas the present study is a damage model. 
Another study showed that FL increased acutely two hours following eccentric muscle 
contractions (Hoffman et al., 2014). This study may have looked at damage but the times 
of assessment were different from the present study which could explain the difference in 
results. The fact that PA did not change suggests that EIMD is possibly independent from 
what happens to FL. The possible decrease in FL may mean the MG is more contracted 
following EIMD indicating increased resting muscle tone and stiffness. These are novel 
findings and deserve further investigation.   
5.3. Tendon Stiffness 
 Tendon stiffness is also a novel measure with EIMD. Muscle stiffness is known to 
increase following EIMD based upon findings of previous studies (Clarkson & Sayers, 
1999; Hoang et al., 2007; Whitehead et al., 2001; Yanagisawa, Sakuma, Kawakami, 
Suzuki, & Fukubayashi, 2015). Using the muscle-tendon junction displacement method 
of tendon stiffness has not been done with EIMD prior to this study limiting our ability to 
understand the relative components of the CC, PEC, and SEC components to stiffness 
changes. The micro-tearing that is known to occur in muscle due to EIMD was thought to 
affect tendon as well; therefore, it was predicted that tendon stiffness would increase 
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following EIMD due to more pull from the increased muscular stiffness and resting 
muscle contraction. 
 To use the muscle-tendon junction displacement method, it was important to first 
determine the moment arm of the muscle. Moment arm was determined three different 
ways: two utilizing tendon-excursion and one determined from anthropometric 
measurements. The first technique of these muscle-tendon junction methods was a single 
rotation method where only one range of motion of the ankle was performed, and the 
ultrasound recording the entire duration. The second technique was five rotations of the 
ankle with ultrasound data being recorded on the fifth full range of motion. No 
differences were found between MA1 and MA2 lending to the concurrent validity of 
these techniques and shows that repeated passive motion does not affect the outcome of 
the muscle-tendon junction method. These methods were also performed at each 
timepoint for all subjects. No change in the moment arm was found due to EIMD 
indicating that the methods have some reliability and are unaffected by EIMD. The third 
method involved anthropometric measurements and picture analysis and was only 
performed at the start of day one of testing. The photo method was significantly different 
from the muscle-tendon junction displacement methods though the results did yield 
values similar to other studies (Scholz, Bobbert, van Soest, Clark, & van Heerden, 2008) 
indicating that the obtained values were concurrently valid. Overall, no one method is 
better than the other in the context of this study as the moment arm is simply a scalar of 
the overall force value, meaning if the moment arm value is consistent and reliable it will 
not drastically alter the force calculation. 
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 Despite the increase found in pain, there was no change in any calculation of 
tendon stiffness. As stated previously other studies showed increases in muscle stiffness 
further supporting the original hypothesis that tendon stiffness would too increase 
(Howell et al., 1993; McHugh et al., 1999). These results indicate previous findings that 
have shown stiffness increases were likely mediated by muscle and not tendon.  
One of the most interesting findings was the lack of force deficit, which is of the 
hallmarks of EIMD (Allen, 2001; Clarkson et al., 1992), despite changes in pain. The 
selected muscle damage protocol could be the reason for the unobserved force decrement 
but that would imply that EIMD did not occur. Our muscle damage protocol was based 
on other isokinetic study designs which yielded both pain and damage (Brown, Day, & 
Donnelly, 1999; Deschenes et al., 2000; Eston, Finney, Baker, & Baltzopoulos, 1996) 
indicating EIMD should have occurred.  It should be noted thought, that these models 
utilized the quadriceps muscle group instead of the triceps surae group; however, both 
muscle groups are pennate and motion was limited to one plane ensuring reliability of 
damage. Therefore, lack of the force deficit could be due to the untrained nature of the 
subjects. Many studies utilize untrained subjects for EIMD without familiarization 
(Brown et al., 1999; Eston et al., 1996; Hoffman et al., 2014; Nosaka & Clarkson, 1995); 
however, a lack of experience with exercise and with the isokinetic dynamometer might 
have contributed small amount to the lack of the force deficit. Despite the movement 
being simple and familiar to subjects, perhaps familiarizing them to the feel of the 
isokinetic dynamometer is warranted in future studies. One other note should be made 
regarding pennate muscle damage. A recent study has shown that the gearing nature of 
pennate muscles may protect them from damage (Azizi & Roberts, 2014). A fusiform 
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muscle model such as the biceps brachii may be more appropriate and increase the 
amount of damage.  
5.4. Reflexive Inhibition 
 Reflexive inhibition describes the segmental ability to excite the motor neuron 
pool, with greater H:M ratios indicating a more excitable alpha motor neuron pool. H-
Reflex allows for measurement of the excitability of the alpha motor neurons as well as 
Type I and Type II afferent fibers. Ligamentous injury alters AMI, with increased type III 
and IV afferent activity secondary to capsular damage and swelling consistently observed 
to increase reflexive inhibition (Palmieri-Smith et al., 2013). This study tested to see if 
altered activity of Type I and Type II afferent fibers can elicit a similar increase in 
reflexive inhibition. EIMD should cause alter activity to the Type I and Type II 
pathways; therefore, it was predicted that reflexive inhibition would increase due to 
muscle damage and altered sensory feedback from Type I and Type II afferents (McVey 
et al., 2005; Palmieri-Smith et al., 2013) as well as AMI response from pain (Palmieri-
Smith, Hopkins, & Brown, 2009). The results showed no change in reflexive inhibition 
following EIMD, and even though pain was present it was not enough to disrupt the 
motor neuron pool. The damage which should occur as a result of EIMD then is not 
enough to cause AMI and possible alterations to Type I and Type II afferents are not 
enough to cause AMI either. It may be concluded then that muscle damage and pain may 
not acutely change the inhibition of the spinal reflexes or cause AMI. 
5.5. Intracortical Inhibition 
CSP is a measure of the GABAergic inhibition inside of the brain and is thought 
to alter resting motor tone of the muscle as well as muscle stiffness, the shorter the silent 
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period, the less inhibition is present resulting in increases to muscle tone as well as 
muscle stiffness. Long term injury is known to increase inhibition in the long term 
leading to disuse and decreased ability to activate the muscle. The effects of acute injury 
though are less known as it is harder to study. Acute injury is thought to decrease the 
level of GABAergic activity due to increased sensory input from the periphery, including 
pain (Needle et al., 2014; Needle, Palmer, et al., 2013). Further, long term muscle tone 
dysfunctions such as dystonia, which reflect increased resting muscle tone, have shown 
decreased inhibition (Hallett, 2011). So, based upon injury findings and the known 
muscle stiffness changes of EIMD (Hoang et al., 2007; McHugh et al., 1999), it was 
predicted that intracortical inhibition would decrease following EIMD. 
 CSP did not change at the 130% stimulation levels following EIMD in the present 
study. There is though a large effect size at the 110% stimulation level (η2 = 0.302), but it 
is underpowered to find (p = 0.135). It would then be improper to conclude there is no 
CSP change. Especially since due to an adverse event, only six subjects of these data 
were obtained; therefore, a larger sample size then may yield significance. It is important 
to note as well that the trend at the 110% stimulation level is a decrease from baseline 
potentially supporting the hypothesis that pain and acute injury lends itself to 
disinhibition. The results seen in FL also may support the change in CSP. A shorter FL 
would indicate that the muscle is more contracted due to more overlap within the 
sarcomeres. All this would indicate a potential change in resting motor tone. Therefore, 
muscle damage may trigger a change in resting muscle tone and intracortical inhibition. 
More data is needed to determine if there is a real effect. 
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5.6. Conclusions 
 The data here suggests that EIMD may be responsible for changes in intracortical 
inhibition and resting muscle tone although more data is needed to support this assertion. 
It also suggests that the effects of EIMD such as feelings of stiffness and force changes is 
likely mediated in part by neurological changes. The lack of mechanical changes seen in 
this study seem to support this conclusion. More research is needed to confirm this link. 
A lack of AMI as well suggests that EIMD models offer differences from ligamentous 
injury. Type III and Type IV afferent fibers likely do not cause the same response as 
damage to Type I and Type II afferents.  
The pain that was found in the present study does indicate that some form of 
damage did take place in the subjects, although the degree to damage may be 
questionable. Future models may be encouraged to track markers of inflammation and 
muscle damage to observe a potential covariate to these neuromechanical changes. There 
are improvements that could be made to this model such as using fusiform muscles and 
trained subjects which may yield better results. Further, it would be prudent to measure 
joint stiffness or muscle stiffness to observe the relative contributions of muscle, tendon, 
and capsule towards perceived increases in stiffness. 
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Tables 
 
Table 1 
 
Descriptive Statistics of Pain Measures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
Walk Pain Mean  
(± Std Dev) 
Stand Pain Mean  
(± Std Dev) 
Sit Pain Mean  
(± Std Dev) 
Pre 0.800 ± 0.646 0.854 ± 0.692 0.838 ± 0.666 
Post 1.337 ± 0.867 1.329 ± 0.728 0.913 ± 0.604 
24 Hours 2.208 ± 1.442*⁺ 1.400 ± 0.973 1.183 ± 0.674 
72 Hours 1.19583 ± 0.929 1.229 ± 0.972 1.075 ± 0.747 
*Significantly different from baseline 
⁺Significantly different from 72 hours 
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Table 2 
 
Descriptive Statistics of PA and FL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Pre Post 24 Hours 72 Hours 
Fascicle Length  
(± Std Dev) (cm) 
9.117 ±  
1.881 
8.460 ± 
2.498 
8.436 ± 
1.765 
7.761 ± 
1.708 
Pennnation Angle  
(± Std Dev) (deg) 
18.389 ± 
3.153 
19.137 ± 
3.287 
18.695 ± 
2.724 
20.083 ± 
2.118 
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Table 3 
 
Descriptive Statistics of Moment Arm 
 
Technique 
Time 
Pre Post 24 Hours 72 Hours 
MA1 (± Std Dev) 
(cm) 
2.603 ± 0.591 2.496 ± 0.724 2.502 ± 0.572 2.523 ± 0.635 
MA1 Goni Corrected 
(± Std Dev) (cm)* 
3.257 ± 0.860 2.858 ± 0.680 3.119 ± 1.005 3.271 ± 0.884 
MA2 (± Std Dev) 
(cm) 
2.668 ± 0.748 2.478 ± 0.639 2.499 ± 0.475 2.465 ± 0.593 
MA2 Goni Corrected 
(± Std Dev) (cm)* 
3.083 ± 0.811 3.047 ± 1.193 3.195 ± 0.758 3.387 ± 1.233 
Manual (Pre-Only) 
(± Std Dev) (cm)† 
5.266 ± 0.466 No difference between timpoints for any technique 
*Significantly different than MA1 and MA2, † Significantly different than MA1, MA2, MA1 Goni Corrected, MA2 Goni 
Corrected 
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Table 4 
 
Descriptive and ANOVA Statistics of Tendon Stiffness 
 
Stiffness 
Range 
Moment 
Arm 
Technique 
Time (Mean ±  Std Dev; N/cm) ANOVA Statistics 
Pre Post 24-hour 72-hour 
 
F-Value P-Value 
50% - 
100% of 
MVIC 
Maximum 
MA1 Raw 
1826.41 ± 
713.58 
2117.04 ± 
818.00 
1915.66 ± 
823.66 
1944.62 ± 
678.95 
0.794 0.506 
MA1 Goni 
Corrected 
1500.77 ± 
677.66 
1819.92 ± 
706.5 
1571.63 ± 
671.22 
1576.01 ± 
704.07 
1.032 0.391 
MA 2 Raw 
1844.37 ± 
960.12 
1973.78 ± 
631.35 
1878.41 
±675.28 
2058.32 ± 
972.02 
0.238 0.869 
MA2 Goni 
Corrected* 
1588.37 ± 
784.17 
1779.40 ± 
1026.82 
1500.22 ± 
654.81 
1728.52 ± 
1199.50 
0.308 0.820 
Manual 
1149.29 ± 
300.58 
1196.87 ± 
339.43 
1143.65 ± 
331.58 
1171.69 ± 
224.31 
0.251 0.860 
Total 
MVIC 
MA1 Raw 
2123.98 ± 
936.92 
2516.94 ± 
1017.64 
2364.58 ± 
1148.42 
2258.74 ± 
659.80 
0.804 0.501 
MA1 Goni 
Corrected 
2048.97 ± 
1021.94 
2388.91 ± 
956.14 
2096.29 ± 
894.14 
2101.63 ± 
938.00 
0.571 0.638 
MA 2 Raw 
2132.19 ± 
1277.90 
2298.49 ± 
707.47 
2269.24 ± 
849.31 
2432.17 ± 
1217.17 
0.234 0.872 
MA2 Goni 
Corrected* 
2505.14 ± 
1565.34 
2672.13 ± 
1517.75 
2500.70 ± 
1510.08 
2763.76 ± 
2069.74 
0.139 0.936 
Manual* 
1354.14 ± 
480.71 
1468.27 ± 
485.54 
1415.53 ± 
599.71 
1389.74 ± 
307.73 
0.227 0.877 
* Indicates Sphericity was violated. Greenhouse-Geiser correction applied for analysis 
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Table 5 
 
Descriptive and ANOVA Statistics of Maximal Isometric Force 
 
 Pre Post 24 Hours 72 Hours F-Value P-Value μp2 
Maximum 
Force (N) 
± Std Dev 
120.918 ± 
44.656 
120.323 ± 
25.118 
126.057 ± 
39.997 
133.761 ± 
38.112 
0.355 0.786 0.022 
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Figures 
 
 
Figure 1: Timeline of Testing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Visit 1
Pain scale, Baseline 
Architecture, Stiffness, 
and Inhibition Measures
MUSCLE DAMAGE 
PROTOCOL
10 minutes rest,
Re-test Inhibition, 
Stiffness, Architecture, 
and pain scale
Visit 2 (24 hours)
Re-test Pain scale, 
Architecture,  Stiffness, 
and Inhibition Measures
Visit 3 (72-hours)
Re-test Pain scale, 
Architecture,  Stiffness, 
and Inhibition Measures
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Figure 2: Image of ultrasound placement 
Superior view 
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Figure 3: Ultrasound Image of MG 
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Figure 4: Foot images used to determine moment arm of ankle, Lateral View (top), 
Medial View (Bottom) 
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Figure 5: Image of tendon stiffness apparatus, 
Superior View (Top), Medial View (Bottom) 
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Figure 6: Placement of electro goniometer, Lateral View 
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Figure 7: Image of TMS apparatus 
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Figure 8: Muscle Damage Range of Motion: End 
Dorsiflexion(left), End Plantarflextion(Right), Medial View 
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Figure 9: Descriptive statistics of H-Reflex 
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Figure 10: Descriptive Statistics of CSP 
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Appendix A 
PAIN SCALES 
 
Using a vertical mark, indicate your level of pain in your lower leg on the scales below: 
 
1) Please rate your current level of pain when walking 
 
 
 
 
           
 
 
2) Please rate your current level of pain when standing 
 
 
            
 
 
3) Please rate your current level of pain while sitting 
 
 
 
 
            
 
 
 
 
 
 
 
 
 
 
 
 
  
No pain 
at all 
Worst Pain 
Imaginable 
No pain 
at all 
Worst Pain 
Imaginable 
No pain 
at all 
Worst Pain 
Imaginable 
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Appendix B 
Consent to Participate in Research 
Information to Consider about this Research 
 
Changes in Tendon Stiffness and Stiffness Regulation Following Exercise Induced 
Muscle Damage 
Principal Investigator: John Mackall  
Department: Health and Exercise science  
Contact Information: mackalljw@appstate.edu 
Faculty Advisor: Alan R. Needle, Ph.D.; needlear@appstate.edu 
 
What is the purpose of this research? 
Exercise-induced muscle damage (EIMD) describes the soreness that one experiences 
after performing weight training. When performing heavy lifting, the muscle experiences a 
small amount of damage and inflammation, which is a normal process allowing for 
processes that make the muscle and tendon stronger. However, the associated soreness 
is often a deterrent for many to continue exercise and resistance training.  
 
In this study, we will look at how exercise-induced muscle damage affects how stiff your 
muscle becomes, as well as how your brain and nervous system change in response to 
the small amounts of inflammation. Understanding these factors will allow for us to better 
understand the effects of injury on the body, allowing for the development of better 
techniques to prevent and treat muscle damage and other types of injury.   
 
Why am I being invited to take part in this research?  
You are invited to participate because you are an able-bodied volunteer between the ages 
of 18-35 that has no current or recent injury in the lower extremity, have not participated 
in regimented training for the past three months, and have no current or past history of 
neurological disorder. If you volunteer to take part in this study, you will be one of about 
15 people to do so. 
 
Are there reasons I should not take part in this research? 
You should not participate in this research if you have any current or past history of cardiac 
issues; seizure or epilepsy, or have an immediate relative with epilepsy; are hearing 
impaired or have ringing in your ears; have implanted medical devices including cochlear 
implants, metal in the brain or skull, an implanted neurostimulator, pacemaker, or a 
medication infusions device; are or may be pregnant; have a history of concussion within 
6 months; experience recurrent bouts of fainting or syncope, or migraines; have a history 
of skull fracture or any skull abnormalities; or have a history of surgery to the brain or 
heart. The use of (or withdrawal from) several medications may also exclude you from 
participating in this study. The principal investigator will present you with a screening 
questionnaire and a list of medications that will determine your eligibility for this study. You 
will also not be allowed to participate in this study if you currently have a lower limb injury 
or are taking part in regimented physical activity.  
 
You should also not participate in this research if you have had an injury that prevented 
you from exercising within the last 3 months.  
What will I be asked to do? 
Complete participation in this study will entail a total of 3 sessions over the course of 72 
hours. The first session will be approximately two hours comprised of baseline testing, 
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exercise protocol and post-tests. The second and third tests will occur 24 and 72 hours 
after the first session with a four-hour margin of error. Both session will be about 30 
minutes and will be a retest of experimental outcomes. 
 
Data Collection Timeline: 
 
All testing will take place in the Appalachian State University Neuromuscular lab 
(Convocation Center Room 083). On the first day you will complete the physical activity 
readiness questionnaire (PAR-Q) and the transcranial magnetic stimulation screening 
questionnaire. We will then obtain baseline measurements of your tendon’s stiffness and 
muscle architecture, spinal excitability, and cortical inhibition. These measures will take 
place in the same order and will be repeated immediately, 24-hours and 72-hours after 
completing a muscle damage protocol.  
 
Tendon Stiffness and Muscle Architecture 
Tendon stiffness and muscle architecture will be tested using ultrasound imaging with the 
sensor placed on your calf muscle.  Ultrasound imaging is a safe technique with very few 
people commenting that it can produce a warming effect. Pictures will be taken of your 
bare foot and ankle. We will use these pictures to determine the moment arm of your foot, 
telling us about its ability to produce force. You will then lie on your front on an isokinetic 
dynamometer which is a padded table and on the end is a footplate run by an electric 
motor. You will then move into a full ankle stretch, followed by performing a heel raise 
against the sled as hard as you can as we look at your Achilles tendon and calf muscle 
using ultrasound.  
 
Spinal Excitability 
Electrical stimulation will be used to study the strength of the reflexes surrounding your 
ankle joint. A stimulating electrode will be placed behind your knee. Brief electrical pulses 
(less than half a second), will be applied while the muscle activity is recorded in your legs. 
The pulses will begin at a low intensity and will be increased in intensity as the muscle 
contraction in your leg is recorded. The intensity of the pulses will be increased until a 
maximal muscle contraction is observed. These pulses will produce a tingling sensation 
with a muscle contraction that will go away shortly after the stimulation. 
 
Cortical Inhibition 
Transcranial magnetic stimulation (TMS) will be used to administer magnetic pulses over 
your head. By measuring your muscles’ responses to the pulses, we can determine the 
DAY 1
Baseline Stiffness, 
Excitability, and 
Inhibition Measures
MUSCLE DAMAGE 
PROTOCOL
Re-test Stiffness, 
Excitability, and 
Inhibition Measures
DAY 2 (24 hours)
Re-test Stiffness, 
Excitability, and 
Inhibtion Measures
DAY 3 (72-hours)
Re-test Stiffness, 
Excitability, and 
Inhibition Measures
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strength of the connections between your brain and your ankle. You will be asked to wear 
a tight fitting cap so that measurements may be made on your head and will be provided 
earplugs to decrease the sound of the machine. You will then be familiarized with the 
magnetic stimulator which sends very short (less than half a second long) pulses through 
a large coil. The coil will touch the top of your head during the stimulation. Once 
familiarized, we will deliver one pulse every 5 seconds at different locations in 
approximately a 3-cm radius on your head. We will target the areas of your brain that 
control the muscles being measured. Up to 50 pulses may be delivered at varying 
intensities to determine your “motor threshold”. Next you will receive 30 pulses at 110, 130 
and 150% (10 at each intensity) of your motor threshold.  
 
While TMS pulses are being delivered, you will be asked to remain seated with either your 
muscles relaxed or contracted slightly as if you stepping on a gas pedal. You will hear a 
click every time the TMS pulse is delivered. The TMS pulse will feel like a tap on your 
head and will cause twitching of your leg muscles. At higher intensities, the TMS pulse 
may cause your forehead or face to twitch. 
 
EIMD Protocol 
The protocol to induce muscle damage will be done by performing standing single-leg calf 
raises on the isokinetic dynamometer. Knees will be kept straight using knee braces. Your 
greatest force production value obtained from tendon stiffness will be used to determine 
the load for the EIMD protocol. Seventy-five percent of this value will be entered into the 
computer of the dynamomteter and you will then perform ten sets of ten repetitions of 
single-leg calf raise. Repetitions will only be eccentric (lowering contractions). A full range 
of motion will be done for each repetition and controlled for by the dynamometer. The 
range of motion will first be assessed prior to exercise with dynamometer. If you are unable 
to complete at least five full sets, we will discontinue your participation in this study. 
 
What are possible harms or discomforts that I might experience during the 
research? 
 
There will likely be muscle soreness that will occur after the exercise protocol. Soreness 
can begin as soon as immediately following exercise and can last as long as a week in 
some cases. Soreness should be limited to the calf muscles as this is the muscle being 
exercised. If the soreness persists for more than 10 days, you should follow-up with your 
physician or another qualified healthcare professional, as well as notifying the principal 
investigator.  
 
There is a mild risk of skin irritation at the location where the muscle sensors are placed, 
but this will usually go away after the sensors are removed. 
 
Rare cases of seizures during or immediately after TMS have been reported. While 
extremely rare utilizing the type of stimulation being used in this study, some cases have 
been reported in individuals without a previous history of seizure or neurological disease. 
This risk is potentially reduced by asking you some questions that might tell us about the 
risks of you experiencing seizure (see TMS screening questionnaire). Individuals who 
have a history of seizures or have been diagnosed with epilepsy will be excluded from this 
study. Metal objects close to the coil may be affected by magnetic stimulation; we will 
therefore exclude individuals who have implants in their head. Some medications may 
contribute to an increased risk of seizure and will also result in exclusion from the study. 
You may feel twitches in the muscles of your arm, leg, or face during the magnetic 
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stimulation, but these twitches should not be painful. There is a possibility of headaches, 
scalp discomfort, or lightheadedness associated with TMS testing. If they occur, these 
effects are usually mild and short-lasting. In rare cases, fainting may occur. 
 
While the use of TMS has the potential to help us better understand the neurological 
effects of exercise-induced muscle damage, you may opt out of this measure if you are 
uncomfortable with the risk level.  
 
The investigator has discussed the risks associated with Transcranial 
Magnetic Stimulation (TMS) with me and, knowing these risks, I still wish 
to participate in this study. Initial 
 
During electrical stimulation, the pulses applied will cause a muscle twitch and tingling 
sensation shooting down the leg that may be uncomfortable; however, each pulse will last 
less than one second and every effort will be made to minimize the amount of pulses that 
must be applied. There may be some minor irritation of the skin around the site of the 
electrode following the experiment. 
 
Are there any reasons you might remove me from the research?  
There may be reasons we will need to remove you from the study, even if you want to stay 
in.  If you experience an injury to either lower extremity between testing sessions, it will be 
at the discretion of the principal investigator whether to allow you to remain in the study. 
Failure to complete five sets of the EIMD Protocol will be grounds for termination. 
Additionally, if you experience any of the adverse reactions mentioned above, we will 
immediately terminate your participation in this study. 
 
If you are pregnant you should not participate in this study. You should remove yourself 
from participation if you become pregnant, or suspect you are pregnant, at any point during 
the study. If you use pain or anti-inflammatory medications (e.g. Tylenol or NSAIDs) you 
will be removed from the study as these medications may modify your response to muscle 
damage. The ultrasound gel in rare occasions causes a topical rash and itching, if this 
occurs the testing will stop and you will be removed from the study. 
 
What are possible benefits of this research? 
There are no direct benefits to volunteers, and you are free to end your participation at 
any time. It is our hope that your participation in this project will improve our understanding 
of how muscle injury changes normal body function. 
 
Will I be paid for taking part in the research? 
There is no compensation for participating in the study.  
 
What will it cost me to take part in this research?  
You are responsible only for arranging transport to and from the laboratory for testing.  
 
How will you keep my private information confidential? 
Your identity will remain confidential and will not be revealed in any publications resulting 
from this work. All data will be stored on a secure long-term storage medium. The data will 
not have any identifiers linking information to you. The results of this study may be used 
for teaching, publications, or presentations at scientific meetings. If your individual results 
are discussed, your identity will be protected by using a study code rather than your name. 
Following completion of this project, the data will be destroyed or transferred to a long-
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term storage medium for use during future research studies. Retained data will be stored 
on an encrypted secure server. 
  
What if I get sick or hurt while participating in this research study?  
In the rare event of an injury during testing, standard emergency procedures will be 
followed. There will be two investigators present at all testing sessions trained in 
emergency procedures and first aid. The testing facility is located within a few minutes of 
several agencies providing emergency treatment.  If you need emergency care while you 
are at the research site, it will be provided to you. If you get hurt or sick when you are not 
at the research site, you should call your doctor or call 911 in an emergency.  If your 
illness or injury could be related to the research, tell the doctors or emergency room staff 
about the research study, the name of the Principal Investigator, and provide a copy of 
this consent form if possible.  Call the study’s adviser, Alan R. Needle, Ph.D. (828-262-
4039) as soon as you can.  He needs to know that you are hurt or ill.    
 
There are procedures in place to help attend to your injuries or provide care for you.  
Costs associated with this care will be billed in the ordinary manner, to you or your 
insurance company.  However, insurance companies, Medicare, and Medicaid may not 
pay bills that are related to research costs.  You should check with your insurance about 
this and talk to the Principal Investigator if you have concerns. 
  
Whom can I contact if I have a question? 
The people conducting this study will be available to answer any questions concerning 
this research, now or in the future.  You may contact the Principal Investigator at 828-262-
4039. If you have questions about your rights as someone taking part in research, contact 
the Appalachian Institutional Review Board Administrator at 828-262-2692 (days), through 
email at irb@appstate.edu or at Appalachian State University, Office of Research 
Protections, IRB Administrator, Boone, NC 28608.  
 
Do I have to participate?   
Your participation in this research is completely voluntary.  If you choose not to volunteer, 
there is no penalty or consequence.  If you decide to take part in the study you can still 
decide at any time that you no longer want to participate. You will not lose any benefits or 
rights you would normally have if you do not participate in the study. 
. 
I have decided I want to take part in this research.  What should I do now? 
If you have read this form, had the opportunity to ask questions about the research and 
received satisfactory answers, and want to participate, then sign the consent form and 
keep a copy for your records.  
 
     _______       
Participant's Name (PRINT)                                 Signature                           
 Date  
 
 
     _______       
Investigator’s Name (PRINT)                               Signature                           
 Date  
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Photography and Video Recording Authorization 
 
With your permission, still pictures (photos) and/or video recordings taken during the study 
may be used in research presentations of the research findings.  Please indicate whether 
or not you agree to having photos or videos used in research presentations by reviewing 
the authorization below and signing if you agree.   
 
Authorization 
 
I hereby release, discharge and agree to save harmless Appalachian State University, its 
successors, assigns, officers, employees or agents, any person(s) or corporation(s) for 
whom it might be acting, and any firm publishing and/or distributing any photograph or 
video footage produced as part of this research,  in whole or in part, as a finished product, 
from and against any liability as a result of any distortion, blurring, alteration, visual or 
auditory illusion, or use in composite form, either intentionally or otherwise, that may occur 
or be produced in the recording, processing, reproduction, publication or distribution of 
any photograph, videotape, or interview, even should the same subject me to ridicule, 
scandal, reproach, scorn or indignity. I hereby agree that the photographs and video 
footage may be used under the conditions stated herein without blurring my identifying 
characteristics.  
 
 
 
             
Participant's Name (PRINT)                                 Signature                           Date   
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Appendix C 
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Appendix D 
Appalachian State University 
Transcranial Magnetic Stimulation Screening Questionnaire 
We need to ask you about these things to ensure you are safe. These help us identify risk 
factors may be associated with seizure during TMS procedures. 
1. Do you have epilepsy or have you ever had a convulsion or 
seizure? 
□ Yes □ No 
2. Do you have any immediate family members with a history of 
epilepsy? 
□ Yes □ No 
3. Have you ever had a fainting spell or syncope? If yes, please 
describe on which occasion(s)? 
 
□ Yes □ No 
4. Have you ever had head trauma that was diagnosed as a 
concussion or was associated with loss of consciousness? If yes, 
how long ago was your most recent concussion? 
 
□ Yes □ No 
5. Do you have any hearing problems or ringing in your ears? □ Yes □ No 
6. Do you have cochlear implants? □ Yes □ No 
7. Are you pregnant or is there a chance you might be? □ Yes □ No 
8. Do you have metal in the brain, skull, or elsewhere in your body 
(e.g., splinters, fragments, clips, etc.)? If so, specify the type of 
metal. 
□ Yes □ No 
9. Do you have an implanted neurostimulator (e.g. DBS, 
epidural/subdural, VNS)? 
□ Yes □ No 
10. Do you have a cardiac pacemaker or intracardiac lines? □ Yes □ No 
11. Do you have a medication infusion device? □ Yes □ No 
12. Do you frequently suffer from migraine headaches? □ Yes □ No 
13. Do you have a history of skull fracture or any present skull 
abnormalities? 
□ Yes □ No 
14. Have you ever had surgery to the brain or heart? □ Yes □ No 
15. Are you taking any medications?  □ Yes □ No 
If so, do they match any of the medications listed on the 
opposite side of this page? 
□ Yes □ No 
   
16. Did you ever undergo TMS in the past?  □ Yes □ No 
If so, were there any problems? □ Yes □ No 
17. Did you ever undergo MRI in the past?  □ Yes □ No 
If so, were there any problems? □ Yes □ No 
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List of Potentially Hazardous Drugs for TMS 
CLASS A 
Medications    
Amitriptyline Chlorpromazine Clozapine Doxepine 
Foscarnet Ganciclovir Imipramine Ketamine 
Maprotiline Nortriptyline Ritonavir Theophylline 
Recreational Drugs    
Alcohol Amphetamines (i.e. 
methamphetamine) 
 
Cocaine MDMA (ecstasy) 
Phenycyclidine (PCP, 
angel dust) 
Gamma-Hydroxybutyrate (GHB) Lysergic acid diethylamide (LSD) 
CLASS B 
Ampicillin (Ominpen, 
Polycillin, Principen) 
Anticholinergics (i.e. 
Atrovent, Albuterol, 
Combivent, DuoNeb) 
Antihistamines (i.e. 
Allegra, Claritin, 
Benadryl) 
Aripiprazole (Abilify) 
BCNU (Carmustine) Bupropion (Wellbutrin, 
Aplenzin) 
Cephalosporins 
(Cephalosproium) 
Chloroquine (Aralen) 
Chlorambucil 
(Leukeran) 
Ciproflaxacin Citalopram (Celexa, 
Cipramil) 
Cyclosporin (USAN, 
BAN) 
Cytosine arabinoside 
(Cytarbine) 
Duloxetine (Cymbalta, 
Yentreve) 
Fluoxetine (Prozac) Fluphenazine 
(Prolixin) 
Fluvoxamine (Luvox) Haloperidol (Haldol) Imipenem (Primaxin) Isoniazid (Laniazid, 
Nydrazid) 
Levofloxacin 
(Levaquin) 
Lithium (Lithoboid, 
Eskalith) 
Mefloquine (Lariam) Methotrexate 
(Trexall, Rhumatrex) 
Metronidazole 
(Flagyl)  
Mianserin (Bolvidon, 
Norval, Tolvon) 
Mirtazapine (Remeron, 
Avanza, Zispin, Reflex) 
Paroxetine (Aropax, 
Paxil) 
Olanzapine (Zyprexa, 
Zydis, Relprevv) 
Penicillin Pimozide (Orap) Quetiapine (Seroquel) 
Reboxetine (Edronax, 
Vestra) 
Risperidone 
(Risperdal) 
Ritalin, Ephedrine, or 
other 
Sympathomimetics 
Sertraline (Zoloft) 
Venlafaxine (Effexor) Vincristine (Oncovin) Ziprasidone (Geodon)  
Additionally, you should not participate in this study if you are undergoing symptoms of 
withdrawal from alcohol, barbiturates, benzodiazepines, meprobamate, or chloral 
hydrate. 
If you are on any other medications (other than listed above) that you are concerned may increase 
the risk for adverse events related to Transcranial Magnetic Stimulation, please let the principle 
For Investigator Use Only: 
If subject answered yes for any question, explain below: 
_____________________________________________________________________
_____________________________________________________________________
______________________________________ 
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investigator know. Additionally, the principal investigator can provide you with a list of medications, 
their uses, and trade names if you are unclear of anything on the above list.  
For questionnaire administrators: 
• Any “Yes” responses to questions must be followed-up with the primary 
investigator of the current study.  
• For question #1, 2, 5, 6, 7, 8, 9, 10, 11, 13, 14, or 15 – any answer of “Yes” 
indicates immediate exclusion from the study. 
• For question #3 & #12 – the primary investigator will follow-up and determine if 
these represent isolated incidents or are frequent occurrences. If frequent 
(occurring more than 4 times per year), the subject will be excluded; however, if 
rare, subjects will be informed of the risks of the study and given the option to 
participate. 
• For question #4 – the primary investigator will follow-up and determine if the 
subject has been symptom free from their concussion for at least 6 months, and 
did not suffer any symptoms of post-concussion related syndrome. If these criteria 
are not met, the subject will be excluded. 
• For questions #16 and 17 – the primary investigator will follow-up and determine 
the complication of previous testing and determine if that risk is still applicable to 
the current protocol (i.e. claustrophobia in an MRI machine will not lead to study 
exclusion). If the complication is still a possible risk, the subject will be excluded. 
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